Stelios Papadopoulos
Founder at EXELIXIS, INC.
Net worth: 39 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michel Vounatsos | M | 62 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 8 years |
| George Scangos | M | 76 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
Fondation Santé
| 25 years |
| Brian Posner | M | 62 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 16 years |
| Joseph Hagan | M | 55 | 8 years | |
| Lynn Schenk | F | 79 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 29 years |
| Maria Freire | M | 69 | 6 years | |
| Robert W. Pangia | M | 72 |
PaineWebber, Inc.
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 37 years |
| Michael Morrissey | M | 63 | 24 years | |
| Eric Rowinsky | M | 67 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 14 years |
| Evangelos Vergetis | M | 45 | 4 years | |
| Caroline Dorsa | F | 64 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 14 years |
| Stephen Sherwin | M | 75 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 14 years |
| Christopher Viehbacher | M | 64 | 2 years | |
| Parag Phoolchand Saxena | M | 69 | 4 years | |
| Richard Mulligan | M | 69 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 15 years |
| Preston Klassen | M | 55 | 1 years | |
| Alexander Denner | M | 54 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 15 years |
| Hoda Jeanne Abou-Jamra | F | - |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The BioExec Institute, Inc. is a network of executives in the life sciences industry. The private company is based in Cambridge, MA. The company was founded in 2004 by Hoda Jeanne Abou-Jamra. Hoda Jeanne Abou-Jamra has been the CEO since 2004. | 20 years |
| Spyridon Artavanis-Tsakonas | M | 77 |
Fondation Santé
| 6 years |
| Nancy L. Leaming | F | 76 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 16 years |
| William Rastetter | M | 76 | 11 years | |
| George Poste | M | 79 |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | 24 years |
| Hugh Rosen | M | 65 | 8 years | |
| Christopher Aker | M | 63 | 13 years | |
| Susan Langer | F | - | 1 years | |
| Michael Hencke | M | - | 12 years | |
| Daniel Penksa | M | 39 | 9 years | |
| Jesus B. Mantas | M | 55 | 5 years | |
| Jeffrey Chell | M | 70 |
National Marrow Donor Program
 National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Part of The Marrow Foundation, National Marrow Donor Program provides treatments for those facing life-threatening blood cancers. The company is based in Minneapolis, MN. | 24 years |
| Priya Singhal | M | 56 | 3 years | |
| Amy Ronneberg | F | 49 |
National Marrow Donor Program
National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Part of The Marrow Foundation, National Marrow Donor Program provides treatments for those facing life-threatening blood cancers. The company is based in Minneapolis, MN. | - |
| Matthew Calistri | M | - |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | - |
| Kathryn J. Collier | F | 56 | 6 years | |
| Jeffrey Hessekiel | M | 55 | 10 years | |
| Patrick Haley | M | 48 | 14 years | |
| Joshua Ruch | M | 74 |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | 9 years |
| Nicole Murphy | F | - | 9 years | |
| Dana Aftab | M | - | 26 years | |
| Jake Nunn | M | 53 | 5 years | |
| Pascale Witz | F | 57 | 7 years | |
| James O'Connor | M | 67 | 9 years | |
| Peter Lamb | M | 63 | 24 years | |
| Geoffrey S. Ginsburg | M | 67 |
Duke University Medical Center
| 24 years |
| Stephen Hall | M | 73 | 11 years | |
| Alan Garber | M | 68 | 19 years | |
| Jeffrey R. Luber | M | 57 | 8 years | |
| Jack Wyszomierski | M | 68 | 20 years | |
| Jacqueline Wright | F | 64 | 3 years | |
| Alice S. Huang | M | 85 | 3 years | |
| Susan T. Hubbard | F | - | 8 years | |
| William Hawkins | M | 70 | 5 years | |
| Harry Wilcox | M | 69 | 9 years | |
| Crispina Calsada | F | 54 | 5 years | |
| Julie Smith | F | 53 | 8 years | |
| David Baltimore | M | 86 | 15 years | |
| Robert Lefkowitz | M | 80 |
Duke University Medical Center
| 51 years |
| Jake Elkins | M | - | 7 years | |
| Robin Kramer | F | 58 | 6 years | |
| Patrick J. Casey | M | 68 |
Duke University Medical Center
| 34 years |
| Ginger Gregory | M | 56 | 7 years | |
| William W. Parker | M | - |
Duke University Medical Center
| - |
| Timothy Haystead | M | - |
Duke University Medical Center
| - |
| David L. Epstein | M | - |
Duke University Medical Center
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kleanthis Xanthopoulos | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 23 years |
| James Mullen | M | 65 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 26 years |
| Timothy Harris | M | 74 |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | 15 years |
| Douglas Swirsky | M | 54 | 11 years | |
| Noubar Afeyan | M | 60 | 16 years | |
| Charles H. Abdalian | M | 73 | 1 years | |
| David Szekeres | M | 50 | 1 years | |
| Paul Grint | M | 66 | 3 years | |
| William Young | M | 79 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 17 years |
| Mark Foletta | M | 63 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 12 years |
| Stephen Worland | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 10 years |
| Paul Clancy | M | 62 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 16 years |
| Daniel Chevallard | M | 44 | 7 years | |
| Anastasia Rader | F | 62 | 10 years | |
| Daphne Karydas | F | 49 | 3 years | |
| Douglas Williams | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 12 years |
| Pieter Muntendam | M | 65 | 8 years | |
| Stéphane Bancel | M | 51 | 5 years | |
| Peter T. Slover | M | 49 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 8 years |
| Cecil B. Pickett | M | 78 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 3 years |
| Michael Rogers | M | 64 |
PaineWebber, Inc.
| 8 years |
| Paul R. Sohmer | M | 75 | 5 years | |
| Michael Joseph Palazzi | M | - |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | 3 years |
| Jeffrey Church | M | 67 | 8 years | |
| James Vincent Lambert | M | 60 | 11 years | |
| Geoff Duyk | M | 64 | 7 years | |
| Charles M. Cohen | M | 73 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 27 years |
| Mary Yaroshevsky-Glanville | F | 59 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 8 years |
| Gilmore O’Neill | M | 59 | 15 years | |
| Craig Eric Schneier | M | 76 | 8 years | |
| Vincent Marchesi | M | 88 | 22 years | |
| Peter Chung | M | - |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | 1 years |
| William Waddill | M | 67 | 4 years | |
| Elizabeth Reed | F | 53 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 11 years |
| Lance Willsey | M | 62 | 26 years | |
| Phillip Sharp | M | 79 | 31 years | |
| Jennifer Drimmer | F | - | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
| Germany | 10 | 10.00% |
| Greece | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stelios Papadopoulos
- Personal Network
